Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koosha Paydary

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Hellenic Journal of Nuclear Medicine|November 10, 2018
Normal patterns of regional brain <sup>18</sup>F-FDG uptake in normal agingSara Pourhassan Shamchi, Mohsen Khosravi, Raheleh Taghvaei, et al.
Blood Advances|November 23, 2018
Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopeniaAllyson M Pishko, Sara Fardin, Daniel S Lefler, et al.
AIDS Research and Treatment|February 1, 2012
Quality of Life among Persons with HIV/AIDS in Iran: Internal Reliability and Validity of an International Instrument and Associated FactorsPedram Razavi, Kaveh Hajifathalian, Behtash Saeidi, et al.
Journal of Clinical Pharmacology|January 10, 2023
In Silico Re-Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure-Response SimulationCody J Peer, Keith T Schmidt, Oluwatobi Arisa, et al.
Hellenic Journal of Nuclear Medicine|November 9, 2016
Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancerBenjapa Khiewvan, Drew A Torigian, Sahra Emamzadehfard, et al.
Journal of Thrombosis and Haemostasis : JTH|July 28, 2019
The risk of major bleeding in patients with suspected heparin-induced thrombocytopeniaAllyson M Pishko, Daniel S Lefler, Phyllis Gimotty, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 7, 2018
<sup>18</sup>F-NaF and <sup>18</sup>F-FDG as molecular probes in the evaluation of atherosclerosisMikaela L McKenney-Drake, Mateen C Moghbel, Koosha Paydary, et al.
Blood|January 21, 2022
Structural racism is a mediator of disparities in acute myeloid leukemia outcomesIvy Elizabeth Abraham, Garth H Rauscher, Anand Ashwin Patel, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Hellenic Journal of Nuclear Medicine|November 10, 2018
Normal patterns of regional brain <sup>18</sup>F-FDG uptake in normal agingSara Pourhassan Shamchi, Mohsen Khosravi, Raheleh Taghvaei, et al.
Blood Advances|November 23, 2018
Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopeniaAllyson M Pishko, Sara Fardin, Daniel S Lefler, et al.
AIDS Research and Treatment|February 1, 2012
Quality of Life among Persons with HIV/AIDS in Iran: Internal Reliability and Validity of an International Instrument and Associated FactorsPedram Razavi, Kaveh Hajifathalian, Behtash Saeidi, et al.
Journal of Clinical Pharmacology|January 10, 2023
In Silico Re-Optimization of Atezolizumab Dosing Using Population Pharmacokinetic Simulation and Exposure-Response SimulationCody J Peer, Keith T Schmidt, Oluwatobi Arisa, et al.
Hellenic Journal of Nuclear Medicine|November 9, 2016
Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancerBenjapa Khiewvan, Drew A Torigian, Sahra Emamzadehfard, et al.
Journal of Thrombosis and Haemostasis : JTH|July 28, 2019
The risk of major bleeding in patients with suspected heparin-induced thrombocytopeniaAllyson M Pishko, Daniel S Lefler, Phyllis Gimotty, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 7, 2018
<sup>18</sup>F-NaF and <sup>18</sup>F-FDG as molecular probes in the evaluation of atherosclerosisMikaela L McKenney-Drake, Mateen C Moghbel, Koosha Paydary, et al.
Blood|January 21, 2022
Structural racism is a mediator of disparities in acute myeloid leukemia outcomesIvy Elizabeth Abraham, Garth H Rauscher, Anand Ashwin Patel, et al.
Pageof 4